Rhizomelic chondrodysplasia punctata is a rare, developmental brain disorder characterized by systemic shortening of the proximal bones (i.e. rhizomelia), seizures, recurrent respiratory tract infections, and congenital cataracts. The affected individuals have low levels of plasmalogens.
In terms of the signs/symptoms of rhizomelic chondrodysplasia punctate one finds the following to be consistent with such a condition:
- Bilateral shortening of the femur
- Post-natal growth problems (deficiency)
- Intellectual disability is present
- Possible seizures
- Possible infections of respiratory tract
This condition is a consequence of mutations in the PEX7 gene, GNPAT gene (which is located on chromosome 1) and AGPS gene, the condition is acquired in a autosomal recessive manner.
The mechanism of rhizomelic chondrodysplasia punctata in the case of "type 1" of this condition one finds that peroxisome objective is PEX7, in peroxisome assembly.There are 3 pathways that "count on" PEX7 and are:
The diagnosis of rhizomelic chondrodysplasia punctate can be based on genetic testing, as well as radiography results, plus an examination(physical) of the individual.
Management of rhizomelic chondrodysplasia punctate can include physical therapy, additionally orthopedic procedures improved function sometimes in affected people. However the prognosis is poor in this condition.